![Ulf Nehrbass](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ulf Nehrbass
Chief Executive Officer at Luxembourg Institute of Health
Ulf Nehrbass active positions
Companies | Position | Start | End |
---|---|---|---|
Luxembourg Institute of Health
![]() Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Chief Executive Officer | - | - |
Career history of Ulf Nehrbass
Former positions of Ulf Nehrbass
Companies | Position | Start | End |
---|---|---|---|
QURIENT CO., LTD. | Chief Executive Officer | 12/08/2011 | - |
Statistics
International
South Korea | 2 |
Luxembourg | 2 |
Operational
Chief Executive Officer | 2 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
QURIENT CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Luxembourg Institute of Health
![]() Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Commercial Services |
- Stock Market
- Insiders
- Ulf Nehrbass
- Experience